Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects

par Dixon, Ruth, Job, Sarah, Oliver, Ruth, Tompson, Debra, Wright, John G, Maltby, Kay, Lorch, Ulrike, Taubel, Jorg
Publié 2008

The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours

par Kelly, Eamonn, Mundell, Stuart J., Sava, Anna, Roth, Adelheid L., Felici, Antonio, Maltby, Kay, Nathan, Pradeep J., Bullmore, Edward T., Henderson, Graeme
Publié dans Psychopharmacology (Berl) (2014)

The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice

par Ripley, Tamzin L., Sanchez-Roige, Sandra, Bullmore, Edward T., Mugnaini, Manolo, Maltby, Kay, Miller, Sam R., Wille, David R., Nathan, Pradeep, Stephens, David N.
Publié dans Psychopharmacology (Berl) (2015)

Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET(A)) antagonist, in the human forearm blood flow model

par Lunnon, Martin W, Wallace, Sharon M L, Palmer, Joanne E, Francis-Lang, Andrew, Laurijssens, Bart E, Mistry, Prafull, Albala, Bruce, Nagafuji, Toshiaki, Wilkinson, Ian B, Maltby, Kay
Publié 2010

Neural and Behavioral Effects of a Novel Mu Opioid Receptor Antagonist in Binge-Eating Obese People

par Cambridge, Victoria C., Ziauddeen, Hisham, Nathan, Pradeep J., Subramaniam, Naresh, Dodds, Chris, Chamberlain, Samuel R., Koch, Annelize, Maltby, Kay, Skeggs, Andrew L., Napolitano, Antonella, Farooqi, I. Sadaf, Bullmore, Edward T., Fletcher, Paul C.
Publié 2013

Effects of the BDNF Val66Met Polymorphism and Met Allele Load on Declarative Memory Related Neural Networks

par Dodds, Chris M., Henson, Richard N., Suckling, John, Miskowiak, Kamilla W., Ooi, Cinly, Tait, Roger, Soltesz, Fruzsina, Lawrence, Phil, Bentley, Graham, Maltby, Kay, Skeggs, Andrew, Miller, Sam R., McHugh, Simon, Bullmore, Edward T., Nathan, Pradeep J.
Publié 2013

The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects

par Ziauddeen, Hisham, Nathan, Pradeep J, Dodds, Chris, Maltby, Kay, Miller, Sam R, Waterworth, Dawn, Song, Kijoung, Warren, Liling, Hosking, Louise, Zucchetto, Mauro, Bush, Mark, Johnson, Lakshmi Vasist, Sarai, Bhopinder, Mogg, Karin, Bradley, Brendan P, Richards, Duncan B, Fletcher, Paul C, Bullmore, Edward T
Publié dans J Clin Pharmacol (2013)

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype

par Ziauddeen, Hisham, Nestor, Liam J, Subramaniam, Naresh, Dodds, Chris, Nathan, Pradeep J, Miller, Sam R, Sarai, Bhopinder K, Maltby, Kay, Fernando, Disala, Warren, Liling, Hosking, Louise K, Waterworth, Dawn, Korzeniowska, Anna, Win, Beta, Richards, Duncan B, Vasist Johnson, Lakshmi, Fletcher, Paul C, Bullmore, Edward T
Publié dans Neuropsychopharmacology (2016)

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype

par Ziauddeen, Hisham, Nestor, Liam J, Subramaniam, Naresh, Dodds, Chris, Nathan, Pradeep J, Miller, Sam R, Sarai, Bhopinder K, Maltby, Kay, Fernando, Disala, Warren, Liling, Hosking, Louise K, Waterworth, Dawn, Korzeniowska, Anna, Win, Beta, Richards, Duncan B, Johnson, Lakshmi Vasist, Fletcher, Paul C, Bullmore, Edward T
Publié dans Neuropsychopharmacology (2018)